PLX038
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PLX038, covering 2026-01-02 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications [Phase 1, Phase 2]